Skip to main content
Equibles

DEUTSCHE BANK AG\

Bank

Position in PHAT — Phathom Pharmaceuticals, Inc.

CIK 948046 FRANKFURT AM MAIN, 2M
Back to PHAT Full portfolio

Position in PHAT

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$544,723
+$139,665 QoQ
Shares Held
50,205
+37.7% QoQ
Ownership
0.062%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#78
of 161 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in PHAT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,199,137,357 across 296 Biotechnology names. PHAT ranks #176 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,579,110 $784,391,303
2 REGN
Regeneron Pharmaceuticals, Inc.
 518,409 $323,248,743
3 ALNY
Alnylam Pharmaceuticals, Inc.
 815,400 $245,459,858
4 RVMD
Revolution Medicines, Inc.
 888,019 $166,308,196
5 RPRX
Royalty Pharma plc
 2,717,951 $152,395,510
6 INCY
Incyte Corp
 1,262,988 $143,172,312
7 ARGX
Argenx SE
 137,335 $127,415,291
8 LGND
Ligand Pharmaceuticals Inc
 249,611 $78,899,539

All Filings in PHAT

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $544,723 50,205
2026-03-31 $405,058 36,459
2025-12-31 $553,773 33,380
2025-09-30 $348,061 29,572
2025-06-30 $250,097 26,079
2025-03-31 $170,367 27,172
2024-12-31 $245,329 30,213
2024-09-30 $365,703 20,227
2024-06-30 $155,230 15,071
2024-03-31 $151,462 14,262
2023-12-31 $161,591 17,699
2023-09-30 $133,036 12,829
2023-06-30 $159,366 11,129
2023-03-31 $115,660 16,199
2022-12-31 $121,658 10,843
2022-09-30 $118,455 10,691
2022-06-30 $85,657 10,149
2022-03-31 $157,072 11,541
2021-12-31 $252,542 12,839
2021-09-30 $391,523 12,197
2021-06-30 $425,460 12,569
2021-03-31 $278,882 7,425
2020-12-31 $268,483 8,082
2020-09-30 $220,422 6,011
2020-06-30 $180,707 5,491
2020-03-31 $95,791 3,710